ArticleJournal of global health2025
Age-period-cohort analysis of cardiovascular disease trends in middle-aged and older adults: cross-country comparison across HRS, ELSA, SHARE, and CHARLS.
Article in Journal of global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Background: Cardiovascular disease (CVD) is a leading cause of death globally, while the dynamics of CVD risk across different age groups, periods, and birth cohorts remain unclear. This study investigates how age, period, and cohort effects contribute to CVD risk across regions differently. Methods: We employed a repeated cross-sectional design, analysing data from four large longitudinal surveys in the USA, UK, Europe, and China. A hierarchical age-period-cohort analysis was conducted using Bayesian inference through the integrated nested Laplace approximation to model the effects of age, period, and cohort on CVD risk across these regions. Subgroup analyses were also conducted to examine the moderation effects of social-demographic factors. Results: CVD risk increases with age across all regions, peaking at age 75 in China while continuously rising in other areas. Period effects showed a significant increase in CVD risk over time in the USA, UK, and China, while a decline was observed in Europe after 2017. More recent birth cohorts showed a lower CVD risk, especially in the USA and UK. In China, the decrease in risk among recent cohorts was less pronounced. Gender, marital status, education, rural residence, and smoking moderated CVD risk trends across regions. Conclusions: This study highlights the importance of age, period, and cohort effects in understanding regional differences in CVD risk among middle-aged and older adults. Findings suggest that public health interventions should be tailored to specific regions and demographic groups to reduce CVD burden effectively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.